These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 16605132)
1. Role of CC chemokines and their receptors in multiple aspects of mast cell biology: comparative protein profiling of FcepsilonRI- and/or CCR1-engaged mast cells using protein chip technology. Toda M; Nakamura T; Ohbayashi M; Ikeda Y; Dawson M; Richardson RM; Alban A; Leed B; Miyazaki D; Ono SJ Novartis Found Symp; 2005; 271():131-40; discussion 140-51. PubMed ID: 16605132 [TBL] [Abstract][Full Text] [Related]
2. Impact of engagement of FcepsilonRI and CC chemokine receptor 1 on mast cell activation and motility. Toda M; Dawson M; Nakamura T; Munro PM; Richardson RM; Bailly M; Ono SJ J Biol Chem; 2004 Nov; 279(46):48443-8. PubMed ID: 15337751 [TBL] [Abstract][Full Text] [Related]
3. Requirement of the tyrosines at residues 258 and 270 of MAIR-I in inhibitory effect on degranulation from basophilic leukemia RBL-2H3. Okoshi Y; Tahara-Hanaoka S; Nakahashi C; Honda S; Miyamoto A; Kojima H; Nagasawa T; Shibuya K; Shibuya A Int Immunol; 2005 Jan; 17(1):65-72. PubMed ID: 15569773 [TBL] [Abstract][Full Text] [Related]
4. Macrophage inflammatory protein-1alpha as a costimulatory signal for mast cell-mediated immediate hypersensitivity reactions. Miyazaki D; Nakamura T; Toda M; Cheung-Chau KW; Richardson RM; Ono SJ J Clin Invest; 2005 Feb; 115(2):434-42. PubMed ID: 15650768 [TBL] [Abstract][Full Text] [Related]
5. C3a-derived peptide binds to the type I FcepsilonR and inhibits proximal-coupling signal processes and cytokine secretion by mast cells. Péterfy H; Tóth G; Pecht I; Erdei A Int Immunol; 2008 Oct; 20(10):1239-45. PubMed ID: 18653698 [TBL] [Abstract][Full Text] [Related]
6. Human mast cell line-1 (HMC-1) cells transfected with FcεRIα are sensitive to IgE/antigen-mediated stimulation demonstrating selectivity towards cytokine production. Xia YC; Sun S; Kuek LE; Lopata AL; Hulett MD; Mackay GA Int Immunopharmacol; 2011 Aug; 11(8):1002-11. PubMed ID: 21356342 [TBL] [Abstract][Full Text] [Related]
7. Differential CCR1-mediated chemotaxis signaling induced by human CC chemokine HCC-4/CCL16 in HOS cells. Kim IS; Jang SW; Sung HJ; Lee JS; Ko J FEBS Lett; 2005 Nov; 579(27):6044-8. PubMed ID: 16226254 [TBL] [Abstract][Full Text] [Related]
8. Identification of genes and proteins specifically regulated by costimulation of mast cell Fcε Receptor I and chemokine receptor 1. Aye CC; Toda M; Morohoshi K; Ono SJ Exp Mol Pathol; 2012 Jun; 92(3):267-74. PubMed ID: 22417871 [TBL] [Abstract][Full Text] [Related]
9. Houttuynia cordata water extract suppresses anaphylactic reaction and IgE-mediated allergic response by inhibiting multiple steps of FcepsilonRI signaling in mast cells. Han EH; Park JH; Kim JY; Jeong HG Food Chem Toxicol; 2009 Jul; 47(7):1659-66. PubMed ID: 19394399 [TBL] [Abstract][Full Text] [Related]
10. PI3Kgamma differentially regulates FcepsilonRI-mediated degranulation and migration of mast cells by and toward antigen. Endo D; Gon Y; Nunomura S; Yamashita K; Hashimoto S; Ra C Int Arch Allergy Immunol; 2009; 149 Suppl 1():66-72. PubMed ID: 19494508 [TBL] [Abstract][Full Text] [Related]
11. Evidence that formation of vimentin mitogen-activated protein kinase (MAPK) complex mediates mast cell activation following FcεRI/CC chemokine receptor 1 cross-talk. Toda M; Kuo CH; Borman SK; Richardson RM; Inoko A; Inagaki M; Collins A; Schneider K; Ono SJ J Biol Chem; 2012 Jul; 287(29):24516-24. PubMed ID: 22613718 [TBL] [Abstract][Full Text] [Related]
12. RabGEF1, a negative regulator of Ras signalling, mast cell activation and skin inflammation. Tam SY; Kalesnikoff J; Nakae S; Tsai M; Galli SJ Novartis Found Symp; 2005; 271():115-24; discussion 124-30, 145-51. PubMed ID: 16605131 [TBL] [Abstract][Full Text] [Related]
13. Role of C-C chemokine receptors 1 and 5 and CCL3/macrophage inflammatory protein-1alpha in the cutaneous Arthus reaction: possible attenuation of their inhibitory effects by compensatory chemokine production. Yanaba K; Mukaida N; Matsushima K; Murphy PM; Takehara K; Sato S Eur J Immunol; 2004 Dec; 34(12):3553-61. PubMed ID: 15517609 [TBL] [Abstract][Full Text] [Related]
14. Assessment of three human FcepsilonRI-transfected RBL cell-lines for identifying IgE induced degranulation utilizing peanut-allergic patient sera and peanut protein extract. Ladics GS; van Bilsen JH; Brouwer HM; Vogel L; Vieths S; Knippels LM Regul Toxicol Pharmacol; 2008 Aug; 51(3):288-94. PubMed ID: 18534732 [TBL] [Abstract][Full Text] [Related]
15. A novel insight to the functional role of Stathmin 1 in IgE-mediated activation of RBL-2H3 cells. Sadroddiny E; Moir AJ; A Helm B Iran J Allergy Asthma Immunol; 2011 Jun; 10(2):73-80. PubMed ID: 21625015 [TBL] [Abstract][Full Text] [Related]
16. PICOT, protein kinase C theta-interacting protein, is a novel regulator of FcepsilonRI-mediated mast cell activation. Kato N; Motohashi S; Okada T; Ozawa T; Mashima K Cell Immunol; 2008 Jan; 251(1):62-7. PubMed ID: 18479680 [TBL] [Abstract][Full Text] [Related]
17. A novel, selective, and orally available antagonist for CC chemokine receptor 3. Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911 [TBL] [Abstract][Full Text] [Related]
18. Gab2 antisense oligonucleotide blocks rat basophilic leukemic cell functions. Chan JH; Liao W; Lau HY; Wong WS Int Immunopharmacol; 2007 Jul; 7(7):937-44. PubMed ID: 17499196 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of parthenolide on antigen-induced microtubule formation and degranulation in mast cells. Miyata N; Gon Y; Nunomura S; Endo D; Yamashita K; Matsumoto K; Hashimoto S; Ra C Int Immunopharmacol; 2008 Jun; 8(6):874-80. PubMed ID: 18442792 [TBL] [Abstract][Full Text] [Related]
20. Role of beta-chemokines in mast cell activation and type I hypersensitivity reactions in the conjunctiva: in vivo and in vitro studies. Beer F; Kuo CH; Morohoshi K; Goodliffe J; Munro P; Aye CC; Dawson M; Richardson RM; Jones LH; Ikeda Y; Nakamura T; Toda M; Flynn T; Ohbayashi M; Miyazaki D; Ono SJ Immunol Rev; 2007 Jun; 217():96-104. PubMed ID: 17498054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]